JUNS Stock Analysis: Buy, Sell, or Hold?
JUNS - Jupiter Neurosciences, Inc. Common Stock
$0.53
-0.07 (-12.03%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
23d
Get Alerted When JUNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: JUNS is down 40.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: JUNS is down 40.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: JUNS is currently trading at $0.53, which is considered oversold relative to its 30-day fair value range of $0.85 to $1.10. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.8) compared to its historical average (17.0). Remarkably, the market is currently pricing in an annual earnings decline of 19.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, JUNS is in a strong downtrend. Immediate support is located at $0.48, while resistance sits at $0.98. Short-term momentum is weak, with the stock down 12.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+5584.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, JUNS is in a strong downtrend. Immediate support is located at $0.48, while resistance sits at $0.98. Short-term momentum is weak, with the stock down 12.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+5584.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.85 -
$1.10
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
74.8%
Protect Your Profits
Holding JUNS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-12.0%)
- BULLISH: Trading 5584.0% below Wall St target ($30.00)
- WARNING: Recommendation downgraded due to -40.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.85 -
$1.10
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.48
Resistance Level
$0.98
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
8.80
Wall Street Target
$30.00
(+5584.0%)
Valuation Discount vs History
-19.7% cheaper
PE vs Historical
8.8 vs 17.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-19.7%
(market-implied from PE analysis)
1-Year Target
$0.48
(-10%)
2-Year Target
$0.43
(-19%)
3-Year Target
$0.38
(-27%)
3-Yr Target (if PE normalizes)
(PE: 9→17)
$0.74
(+41%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.8 to 17.0
Stabilization Target:
$1.02
(+93.3%)
PE Expansion Potential:
+93.3%
Last updated: February 01, 2026 8:12 AM ET
Data refreshes hourly during market hours. Next update: 9:12 AM
Data refreshes hourly during market hours. Next update: 9:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JUNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$85 | 55 HOLD |
Advanced JUNS Option Strategies
Professional options setups generated by AI based on today's JUNS price and gamma walls.
